ID

23801

Beschreibung

Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00581269

Link

https://clinicaltrials.gov/show/NCT00581269

Stichworte

  1. 14.07.17 14.07.17 -
Hochgeladen am

14. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Chronic Kidney Disease NCT00581269

Eligibility Chronic Kidney Disease NCT00581269

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with stage iii-iv (estimated gfr 20-59 min/ml) chronic kidney disease measured by mdrd formula.
Beschreibung

Chronic Kidney Disease Stage | MDRD formula eGFR

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0699749
UMLS CUI [2,1]
C3839656
UMLS CUI [2,2]
C3811844
2. bmi ≥ 30 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
3. age > 18 or < 65 years.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
4. life expectancy greater than one year.
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
5. ability to understand and provide informed consent for participation in the study.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. active inflammatory disease such as: aids (hiv seropositivity is not an exclusion criteria), active hepatitis c or b, active gout, other active inflammatory diseases.
Beschreibung

Inflammatory disorder | AIDS | HIV Seropositivity Excluded | Hepatitis C | Hepatitis B | Gout

Datentyp

boolean

Alias
UMLS CUI [1]
C1290884
UMLS CUI [2]
C0001175
UMLS CUI [3,1]
C0019699
UMLS CUI [3,2]
C2828389
UMLS CUI [4]
C0019196
UMLS CUI [5]
C0019163
UMLS CUI [6]
C0018099
2. active malignancy excluding basal or squamous cell carcinoma of the skin.
Beschreibung

Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
3. patients suffering from type i diabetes mellitus
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
4. patients with reduced daily caloric intake at baseline (≤ 2000 kcal/day) or malnutrition.
Beschreibung

Calorie intake per day Reduced | Malnutrition

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2095644
UMLS CUI [1,2]
C0392756
UMLS CUI [2]
C0162429
5. patients who are already on a consistent and rigorous exercise regimen.
Beschreibung

Exercise regime Consistent Strenuous

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0454291
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C1514989
6. gastrointestinal dysfunction requiring parental nutrition.
Beschreibung

Gastrointestinal dysfunction | Parenteral Nutrition Patient need for

Datentyp

boolean

Alias
UMLS CUI [1]
C0679407
UMLS CUI [2,1]
C0030547
UMLS CUI [2,2]
C0686904
7. history of functional kidney transplant < 6 months prior to study entry.
Beschreibung

Kidney Transplantation Functional

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C0205245
8. anticipated live donor kidney transplant over study duration.
Beschreibung

Live donor renal transplant Expected

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0401177
UMLS CUI [1,2]
C1517001
9. patients taking anti-inflammatory medication except aspirin < 325mg/day over the past 30 days.
Beschreibung

Anti-Inflammatory Agents | Aspirin

Datentyp

boolean

Alias
UMLS CUI [1]
C0003209
UMLS CUI [2]
C0004057
10. patients taking vitamin e supplements > 60 iu/day, vitamin c > 500mg/day over the past 30days.
Beschreibung

Vitamin E supplement U/day | Ascorbic Acid U/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3661607
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0003968
UMLS CUI [2,2]
C0456683
11. patients taking any prednisone therapy.
Beschreibung

Prednisone

Datentyp

boolean

Alias
UMLS CUI [1]
C0032952
12. hospital admission within the last 30 days.
Beschreibung

Hospital admission

Datentyp

boolean

Alias
UMLS CUI [1]
C0184666
13. on experimental drug protocols.
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
14. significant cardiac or vascular disease (symptomatic disease; cv event(s) within the last year; significant occlusive atherosclerotic disease or ischemic disease on non-invasive or invasive diagnostic procedures).
Beschreibung

Heart Disease | Vascular Disease | Disease Symptomatic | Cardiovascular event | Atherosclerotic occlusive disease | Ischemia | Diagnosis, Noninvasive | Diagnostic procedure Invasive

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0042373
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0231220
UMLS CUI [4]
C1320716
UMLS CUI [5]
C0543822
UMLS CUI [6]
C0022116
UMLS CUI [7]
C0259832
UMLS CUI [8,1]
C0430022
UMLS CUI [8,2]
C0205281
15. significant physical disability or immobility (joint disease, joint replacement, muscular disorders).
Beschreibung

Physical disability | Immobility | Arthropathy | Replacement; joint | Myopathy

Datentyp

boolean

Alias
UMLS CUI [1]
C0520817
UMLS CUI [2]
C0231441
UMLS CUI [3]
C0022408
UMLS CUI [4]
C1442800
UMLS CUI [5]
C0026848

Ähnliche Modelle

Eligibility Chronic Kidney Disease NCT00581269

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Kidney Disease Stage | MDRD formula eGFR
Item
1. patients with stage iii-iv (estimated gfr 20-59 min/ml) chronic kidney disease measured by mdrd formula.
boolean
C1561643 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
C3839656 (UMLS CUI [2,1])
C3811844 (UMLS CUI [2,2])
Body mass index
Item
2. bmi ≥ 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Age
Item
3. age > 18 or < 65 years.
boolean
C0001779 (UMLS CUI [1])
Life Expectancy
Item
4. life expectancy greater than one year.
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
5. ability to understand and provide informed consent for participation in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Inflammatory disorder | AIDS | HIV Seropositivity Excluded | Hepatitis C | Hepatitis B | Gout
Item
1. active inflammatory disease such as: aids (hiv seropositivity is not an exclusion criteria), active hepatitis c or b, active gout, other active inflammatory diseases.
boolean
C1290884 (UMLS CUI [1])
C0001175 (UMLS CUI [2])
C0019699 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0019196 (UMLS CUI [4])
C0019163 (UMLS CUI [5])
C0018099 (UMLS CUI [6])
Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin
Item
2. active malignancy excluding basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
Diabetes Mellitus, Insulin-Dependent
Item
3. patients suffering from type i diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Calorie intake per day Reduced | Malnutrition
Item
4. patients with reduced daily caloric intake at baseline (≤ 2000 kcal/day) or malnutrition.
boolean
C2095644 (UMLS CUI [1,1])
C0392756 (UMLS CUI [1,2])
C0162429 (UMLS CUI [2])
Exercise regime Consistent Strenuous
Item
5. patients who are already on a consistent and rigorous exercise regimen.
boolean
C0454291 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C1514989 (UMLS CUI [1,3])
Gastrointestinal dysfunction | Parenteral Nutrition Patient need for
Item
6. gastrointestinal dysfunction requiring parental nutrition.
boolean
C0679407 (UMLS CUI [1])
C0030547 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
Kidney Transplantation Functional
Item
7. history of functional kidney transplant < 6 months prior to study entry.
boolean
C0022671 (UMLS CUI [1,1])
C0205245 (UMLS CUI [1,2])
Live donor renal transplant Expected
Item
8. anticipated live donor kidney transplant over study duration.
boolean
C0401177 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
Anti-Inflammatory Agents | Aspirin
Item
9. patients taking anti-inflammatory medication except aspirin < 325mg/day over the past 30 days.
boolean
C0003209 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
Vitamin E supplement U/day | Ascorbic Acid U/day
Item
10. patients taking vitamin e supplements > 60 iu/day, vitamin c > 500mg/day over the past 30days.
boolean
C3661607 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003968 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Prednisone
Item
11. patients taking any prednisone therapy.
boolean
C0032952 (UMLS CUI [1])
Hospital admission
Item
12. hospital admission within the last 30 days.
boolean
C0184666 (UMLS CUI [1])
Investigational New Drugs
Item
13. on experimental drug protocols.
boolean
C0013230 (UMLS CUI [1])
Heart Disease | Vascular Disease | Disease Symptomatic | Cardiovascular event | Atherosclerotic occlusive disease | Ischemia | Diagnosis, Noninvasive | Diagnostic procedure Invasive
Item
14. significant cardiac or vascular disease (symptomatic disease; cv event(s) within the last year; significant occlusive atherosclerotic disease or ischemic disease on non-invasive or invasive diagnostic procedures).
boolean
C0018799 (UMLS CUI [1])
C0042373 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
C1320716 (UMLS CUI [4])
C0543822 (UMLS CUI [5])
C0022116 (UMLS CUI [6])
C0259832 (UMLS CUI [7])
C0430022 (UMLS CUI [8,1])
C0205281 (UMLS CUI [8,2])
Physical disability | Immobility | Arthropathy | Replacement; joint | Myopathy
Item
15. significant physical disability or immobility (joint disease, joint replacement, muscular disorders).
boolean
C0520817 (UMLS CUI [1])
C0231441 (UMLS CUI [2])
C0022408 (UMLS CUI [3])
C1442800 (UMLS CUI [4])
C0026848 (UMLS CUI [5])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video